Title: Chapter 9 Oncogenes Contents How Cellular Oncogenes Arise
1Contents
How Cellular Oncogenes Arise Proteins Produced by
Oncogenes
2How cellular oncogenes arise
3Cellular oncogenes arise from proto-oncogenes
- Proto-oncogenes are not bad genes
- Normal genes for regulation of cell proliferation
and survival - When it change the structure and activity by
mutation causing cancer - Gain-of-function mutation
4Cellular oncogenes were initially detected in
gene transfer experiments
- Gene transfer test Isolate tumor cells DNA ?
introduce into normal cells ? transformation test - In 1980S, human bladder cancers DNA ? mouse cells
? cancer - Gene cloning techniques gene size fragment of
DNA - First human cellular oncogene RAS oncogen
- Cellular oncogene and viral oncogene
- RAS oncogene and v-ras
- Cellular oncogene arise mechanism point mutation
(2) gene amplification (3) chromosomal
translocation (4) DNA rearrangement (5)
insertional mutagenesis
5Mechanism 1 point mutation can convert
proto-oncogenes into oncogenes
- Difference of normal RAS gene (proto-oncogene)
and abnormal RAS gene (an oncogene) a single
nucleotide base (F. 9-1) - RAS oncogene point mutation is detected in cancer
of bladder, lung, colon, pancrease, and thyroid - Mutation of RAS gene by carcinogens asbestos,
vinyl chloride, dimethylbenzanthracene - RET gene ? RET oncogene (by point mutation) ?
abnormal Ret receptor protein
6How Cellular Oncogenes Arise
7Mechanism 2 gene amplification can convert
proto-oncogenes into oncogenes
- Replicating of DNA in specific chromosome region
- F. 9-2
- The main types examined by light microscopy
homogeneously staining regions (HSRs) and double
minutes (DMs) - Amplified DNA containing from several dozen to
several hundred copies of one or more genes - Most amplified genes are actively expressed
- Produce normal but excessive protein
- MYC gene family MYC, MYCL, MYCN
- By gene amplification for human cancer
- F. 9-3
8- ERBB2 gene amplification involved in 25 of all
breast and ovarian cancers - MYCN gene amplication neuroblastoma
9How Cellular Oncogenes Arise
10How Cellular Oncogenes Arise
11Mechanism 3 chromosomal translocation can
convert proto-oncogene into oncogene
- Philadelphia chromosome chromosome 22 abnormal
- Associated with 90 chronic myelogeneous leukemia
(CML) - Chromosome 9 and 22 reciprocal chromosome
exchange - ABL and BCR gene (F. 9-4) BCR-ABL fusion gene
(in chromosome 22) - fusion protein production
12- Chromosome 8 and 14 translocation Burkitts
lymphoma - MYC proto-oncogene translocation
- Overexpression of normal Myc protein
- Chromosome 3-5, 6-9, 7-11, 8-16, 9-12, 12-22,
16-21 translocation for cancer development
13How Cellular Oncogenes Arise
14Mechanism 4 local DNA rearrangements can convert
proto-oncogenes into oncogenes
- F. 9-5
- DNA deletions, insertions, transpositions, and
inversions - TRK oncogene fusion gene
- Trk fusion protein
- (F. 9-6)
15How Cellular Oncogenes Arise
16How Cellular Oncogenes Arise
17Mechanism 5 insertional mutagenesis can convert
proto-oncogenes into oncogenes
- Cancer virus gene insertion
18Summing up cellular oncogenes arise from
proto-oncogenes by mechanisms that alter gene
structure or expression
19How Cellular Oncogenes Arise
20Proteins produced by oncogenes
- Table 9-1
- Most of the proteins produced by oncogene are
components of signaling pathways that promote
cell proliferation and survival
21Proteins Produced by Oncogenes
22Proteins Produced by Oncogenes
23Oncogenes typically code for components of
signaling pathways that activate cell
proliferation
- Example Ras-MAPK pathway (F. 9-8)
- One of several signaling mechanisms
24Proteins Produced by Oncogenes
25Some oncogenes produce growth factors
- v-sis oncogene (from simian sarcoma virus)
- Mutant form PDGF
26Some oncogenes produce receptor proteins
- F. 9-9
- v-erb-b oncogene constitutively active EFG
receptor (F. 9-9b) - ERBB2 gene overexpression of receptor (F. 9-9c)
- Jak-STAT pathway (F. 9-10)
- STAT ( Signal Transduction and Activators of
Transcript) a cytoplasmic protein - v-mpl oncogene code for a mutant receptor for
thrombopoietin - Trigger a Jak-STAT pathway
27Proteins Produced by Oncogenes
28Proteins Produced by Oncogenes
29Some oncogenes produce plasma membrane G protein
- F. 9-11
- RAS proto-oncogene HRAS, KRAS, and NRAS
- Point mutation abnormal Ras protein production
- Hyperactive Ras protein (binding with GTP)
- 30 of all human cancer
- KRAS is the most frequently mutated in human
cancers
30Proteins Produced by Oncogenes
31Some oncogenes produce intracellular protein
kinases
- Intracellular serine/threonine kinases
- BRAF oncogene mutant form Raf kinase
- 2/3 melanomas
- Tyrosine kinase are also involved in
intracellular signaling pathways (nonreceptor
tyrosine kinase) - Three examples of nonreceptor tyrosine kinases
- Src kinase phosphorylated receptor
- Jak kinase
- Chromosome 9 and 12 TEL-JAK2 fused gene
- Tyrosine kinase activity in Jak kinase
- Abl kinase
- ABL proto-oncogene
- BCR-ABL oncogene for abnormal version of the Abl
tyrosine kinase - Cannot trigger apoptosis
32Some oncogenes produce transcription factors
- Myc protein
- avian leukosis virus (retro virus)
- Enhance normal Myc protein expression
- avian myelocytomatosis virus
- v-myc oncogene
- Abnormal Myc protein
- Epstein-Barr virus
- MYC gene translocation (to chromosome 14)
- Burkitts lymphoma
- Myc is just one of several transcription factors
that produced by oncogenes - v-fos, v-jun, v-myb, v-ets, and v-erb-a
33Some oncogenes produce cell cycle or cell death
regulators
- For Cdks and cyclins
- CDK4 gene
- CYCD1 gene for cyclin
- BCL2 gene Bcl2 protein
34Summing up oncogene-induced disruptions in
signaling pathways exhibit some common themes